Advertisement

Psychotic Symptoms in Frontotemporal Dementia

  • Devin Hall
  • Elizabeth C. FingerEmail author
Behavior (HS Kirshner, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Behavior

Abstract

Although psychotic features have long been recognized in association with frontotemporal dementia (FTD), recent genetic discoveries enabling further subtyping of FTD have revealed that psychotic symptoms are frequent in some forms of FTD. Hallucinations and delusions can even precede onset of other cognitive or behavioural symptoms in patients with FTD. In this review, we explore the frequency and types of psychotic symptoms reported in patients with FTD, as well as in other neuropsychiatric disorders, to aid practitioners’ consideration of these features in the diagnosis of FTD and related disorders.

Keywords

Frontotemporal dementia Psychosis Hallucinations Delusions 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

The authors declare that they have no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Gustafson L, Risberg J. Delusions and hallucinations in old age. In: Katona C, Lewy R, editors. Delusions and hallucinations in old age. London: Gaskell; 1992. p. 218–29.Google Scholar
  2. 2.
    Lillo P et al. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2010;67(7):826–30.CrossRefPubMedGoogle Scholar
  3. 3.•
    Sha SJ et al. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology. 2012;79(10):1002–11. This is one of the seminal papers describing the most common presenting symptoms, including psychosis, in a cohort of patients with FTD and C9ORF72 mutations.CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    van Blitterswijk M et al. Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. Mol Neurodegener. 2014;9:38.CrossRefPubMedCentralPubMedGoogle Scholar
  5. 5.•
    Snowden JS et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135(Pt 3):693–708. This report describes a large cohort of patients with FTD and provides excellent detailed descriptions of psychotic symptoms in FTD patients with and without C9ORF72 mutations.CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Schoder D et al. Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia. Br J Psychiatry. 2010;197(1):28–35.CrossRefPubMedGoogle Scholar
  7. 7.•
    Landqvist Waldo M et al. Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma? Int Psychogeriatr. 2015;27(4):531–9. This is one of the largest autopsy-confirmed studies to date to examine correlations between the presence and type of psychotic symptoms and patterns of atrophy in 97 consecutive patients with confirmed FTLD. CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Omar R et al. Delusions in frontotemporal lobar degeneration. J Neurol. 2009;256(4):600–7.CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Le Ber I et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain. 2008;131(Pt 3):732–46.CrossRefPubMedGoogle Scholar
  10. 10.
    Bathgate D et al. Behaviour in frontotemporal dementia, Alzheimer’s disease and vascular dementia. Acta Neurol Scand. 2001;103(6):367–78.CrossRefPubMedGoogle Scholar
  11. 11.
    Kertesz A et al. Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort. Cogn Behav Neurol. 2013;26(3):146–54.CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    Harciarek M, Kertesz A. The prevalence of misidentification syndromes in neurodegenerative diseases. Alzheimer Dis Assoc Disord. 2008;22(2):163–9.Google Scholar
  13. 13.
    Leger GC, Banks SJ. Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia. Dement Geriatr Cogn Disord. 2014;37(1-2):104–12.CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    Mendez MF et al. Clinicopathologic differences among patients with behavioral variant frontotemporal dementia. Neurology. 2013;80(6):561–8.CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Mahoney CJ et al. Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimers Res Ther. 2012;4(5):41.CrossRefPubMedCentralPubMedGoogle Scholar
  16. 16.
    Hsiung GY et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain. 2012;135(Pt 3):709–22.CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Dobson-Stone C et al. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology. 2012;79(10):995–1001.CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Boeve BF, Graff-Radford NR. Cognitive and behavioral features of c9FTD/ALS. Alzheimers Res Ther. 2012;4(4):29.CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Le Ber I. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm. Rev Neurol (Paris). 2013;169(10):811–9.CrossRefGoogle Scholar
  20. 20.
    Boeve BF et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135(Pt 3):765–83.CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Cruts M, Kumar-Singh S, Van Broeckhoven C. Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Curr Alzheimer Res. 2006;3(5):485–91.CrossRefPubMedGoogle Scholar
  22. 22.
    Chen-Plotkin AS et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 2011;68(4):488–97.CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Le Ber I et al. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat. 2007;28(9):846–55.CrossRefPubMedGoogle Scholar
  24. 24.
    Seelaar H et al. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry. 2011;82(5):476–86.CrossRefPubMedGoogle Scholar
  25. 25.
    Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol. 2012;8(8):423–34.PubMedCentralPubMedGoogle Scholar
  26. 26.
    Khan BK et al. Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman. Psychosomatics. 2012;53(3):280–4.CrossRefPubMedCentralPubMedGoogle Scholar
  27. 27.
    Velakoulis D et al. Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry. 2009;194(4):298–305.CrossRefPubMedGoogle Scholar
  28. 28.
    Mendez MF et al. Psychotic symptoms in frontotemporal dementia: prevalence and review. Dement Geriatr Cogn Disord. 2008;25(3):206–11.CrossRefPubMedGoogle Scholar
  29. 29.
    Passant U et al. Psychiatric symptoms and their psychosocial consequences in frontotemporal dementia. Alzheimer Dis Assoc Disord. 2005;19 Suppl 1:S15–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Harciarek M et al. Schizophrenia and frontotemporal dementia: shared causation? Int Rev Psychiatry. 2013;25(2):168–77.CrossRefPubMedGoogle Scholar
  31. 31.
    Pose M et al. The overlap of symptomatic dimensions between frontotemporal dementia and several psychiatric disorders that appear in late adulthood. Int Rev Psychiatry. 2013;25(2):159–67.CrossRefPubMedGoogle Scholar
  32. 32.
    Momeni P et al. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. Clin Neurol Neurosurg. 2010;112(10):917–20.CrossRefPubMedGoogle Scholar
  33. 33.
    Momeni P et al. Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia. Neurocase. 2010;16(3):273–9.CrossRefPubMedCentralPubMedGoogle Scholar
  34. 34.
    Yoshino, Y., et al., No abnormal hexanucleotide repeat expansion of C9ORF72 in Japanese schizophrenia patients. J Neural Transm, 2014.Google Scholar
  35. 35.
    Huey ED et al. C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiol Aging. 2013;34(4):1309 e9–10.CrossRefGoogle Scholar
  36. 36.
    Galimberti D et al. C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia. Neurobiol Aging. 2014;35(5):1214.e7–10.CrossRefGoogle Scholar
  37. 37.
    Cooper JJ, Ovsiew F. The relationship between schizophrenia and frontotemporal dementia. J Geriatr Psychiatry Neurol. 2013;26(3):131–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Harris MJ, Jeste DV. Late-onset schizophrenia: an overview. Schizophr Bull. 1988;14(1):39–55.CrossRefPubMedGoogle Scholar
  39. 39.
    Shenton ME et al. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49(1-2):1–52.CrossRefPubMedCentralPubMedGoogle Scholar
  40. 40.
    Snowden JS et al. Psychosis, C9ORF72 and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2012;83(10):1031–2.CrossRefPubMedGoogle Scholar
  41. 41.
    McKeith I. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9(3 Suppl):417–23.PubMedGoogle Scholar
  42. 42.
    Engelborghs S et al. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry. 2005;20(11):1028–37.CrossRefPubMedGoogle Scholar
  43. 43.
    Craig D et al. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer’s disease. Am J Geriatr Psychiatr. 2005;13(6):460–8.CrossRefGoogle Scholar
  44. 44.
    Paulsen JS et al. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology. 2000;54(10):1965–71.CrossRefPubMedGoogle Scholar
  45. 45.
    Tariot PN et al. The behavior rating scale for dementia of the consortium to establish a registry for Alzheimer’s disease. The behavioral pathology committee of the consortium to establish a registry for Alzheimer’s disease. Am J Psychiatry. 1995;152(9):1349–57.CrossRefPubMedGoogle Scholar
  46. 46.
    Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer’s disease. I: disorders of thought content. Br J Psychiatry. 1990;157:72–6.Google Scholar
  47. 47.
    Mendez MF et al. False reports from patients with frontotemporal dementia: delusions or confabulations? Behav Neurol. 2011;24(3):237–44.CrossRefPubMedGoogle Scholar
  48. 48.
    Chan D et al. The clinical profile of right temporal lobe atrophy. Brain. 2009;132(Pt 5):1287–98.CrossRefPubMedGoogle Scholar
  49. 49.
    Bruen PD et al. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain. 2008;131(Pt 9):2455–63.CrossRefPubMedGoogle Scholar
  50. 50.
    Whitehead D et al. Frontotemporal atrophy associated with paranoid delusions in women with Alzheimer’s disease. Int Psychogeriatr. 2012;24(1):99–107.CrossRefPubMedGoogle Scholar
  51. 51.
    Serra L et al. Are the behavioral symptoms of Alzheimer’s disease directly associated with neurodegeneration? J Alzheimers Dis. 2010;21(2):627–39.PubMedGoogle Scholar
  52. 52.
    Ismail Z et al. Neuroimaging of delusions in Alzheimer’s disease. Psychiatry Res. 2012;202(2):89–95.CrossRefPubMedGoogle Scholar
  53. 53.
    Mendez MF, Ramirez-Bermudez J. Cotard syndrome in semantic dementia. Psychosomatics. 2011;52(6):571–4.CrossRefPubMedCentralPubMedGoogle Scholar
  54. 54.
    Gramaglia C et al. Early onset frontotemporal dementia with psychiatric presentation due to the C9ORF72 hexanucleotide repeat expansion: a case report. BMC Neurol. 2014;14(1):228.CrossRefPubMedCentralPubMedGoogle Scholar
  55. 55.
    Kobayashi T et al. Effectiveness of electroconvulsive therapy for depression and Cotard’s syndrome in a patient with frontotemporal lobe dementia. Case Rep Psychiatry. 2012;2012:627460.PubMedCentralPubMedGoogle Scholar
  56. 56.
    Pijnenburg YA et al. Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration. Int J Geriatr Psychiatry. 2003;18(1):67–72.CrossRefPubMedGoogle Scholar
  57. 57.
    Arighi A et al. Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. J Alzheimers Dis. 2012;31(2):447–52.PubMedGoogle Scholar
  58. 58.
    Loy CT et al. The case of a 48 year-old woman with bizarre and complex delusions. Nat Rev Neurol. 2010;6(3):175–9.CrossRefPubMedGoogle Scholar
  59. 59.
    Arosio B et al. GRN Thr272fs clinical heterogeneity: a case with atypical late onset presenting with a dementia with Lewy bodies phenotype. J Alzheimers Dis. 2013;35(4):669–74.Google Scholar
  60. 60.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders fifth edition. Washington, DC: American Psychiatric Publishing; 2013.Google Scholar
  61. 61.
    Caliyurt O et al. Cotard’s syndrome with schizophreniform disorder can be successfully treated with electroconvulsive therapy: case report. J Psychiatry Neurosci. 2014;29(2):138–41.Google Scholar
  62. 62.
    Debruyne H et al. Cotard’s syndrome: a review. Curr Psychiatry Rep. 2009;11(3):197–202.Google Scholar
  63. 63.
    Langdon R et al. The Fregoli delusion: a disorder of person identification and tracking. Top Cogn Sci. 2014;6(4):615–31.Google Scholar
  64. 64.
    Simon-Sanchez J et al. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain. 2012;135(Pt 3):723–35.Google Scholar
  65. 65.
    Tartaglia MC et al. Delusions and hallucinations in frontotemporal dementia: a clinicopathologic case report. Cogn Behav Neurol. 2008;21(2):107–10.Google Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Clinical Neurological Sciences, Schulich School of Medicine and DentistryWestern UniversityLondonCanada
  2. 2.Lawson Health Research InstituteLondonCanada
  3. 3.University Hospital, University of Western OntarioLondonCanada

Personalised recommendations